Literature DB >> 12568495

Non-allergic models of mucous cell metaplasia and mucus hypersecretion in rat nasal and pulmonary airways.

Jack R Harkema1, James G Wagner.   

Abstract

Mucous cell proliferation and hypersecretion of airway mucus are important pathological features of human respiratory disorders such as asthma and chronic bronchitis. In addition to airborne allergens and infectious agents, inhaled chemical irritants such as ozone and cigarette smoke have been demonstrated to induce changes in airway mucus production. Cellular and molecular mechanisms involved in non-allergic, toxicant-induced mucous cell metaplasia (MCM; transformation of airway epithelium, normally devoid of mucous cells, to secretory epithelium containing numerous mucus-secreting cells) are still unclear. We have used two experimental models of toxicant-induced MCM in the airways of rats to study the epithelial and inflammatory factors involved in the pathogenesis of MCM. Mucin-specific gene expression and MCM are induced in the nasal transitional epithelium (NTE), but not in the bronchiolar epithelium of F344 rats acutely exposed to ozone, an important air pollutant of photochemical smog. Inhalation of endotoxin, a lipopolysaccharide-protein molecule of gram-negative bacteria, induces MCM in the bronchiolar epithelium, but not in the NTE, of rats. Both ozone- and endotoxin-induced MCM are dependent on neutrophilic inflammation. Interestingly, each toxicant enhances the MCM induced by the other toxicant. These synergistic effects elicited by coexposure to ozone and endotoxin are also mediated, in part, by neutrophils.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12568495

Source DB:  PubMed          Journal:  Novartis Found Symp        ISSN: 1528-2511


  4 in total

1.  Rebuttal from Professor Helmut H. Popper.

Authors:  Helmut H Popper
Journal:  Transl Lung Cancer Res       Date:  2017-04

Review 2.  Targeting mucus hypersecretion: new therapeutic opportunities for COPD?

Authors:  Clémence Martin; Justine Frija-Masson; Pierre-Régis Burgel
Journal:  Drugs       Date:  2014-07       Impact factor: 9.546

3.  Pulmonary mucinous adenocarcinomas: architectural patterns in correlation with genetic changes, prognosis and survival.

Authors:  Abidin Geles; Ulrike Gruber-Moesenbacher; Franz Quehenberger; Claudia Manzl; Mohamed Al Effah; Elisabeth Grygar; Freyja Juettner-Smolle; Helmut H Popper
Journal:  Virchows Arch       Date:  2015-10-08       Impact factor: 4.064

Review 4.  Models of chronic obstructive pulmonary disease.

Authors:  David A Groneberg; K Fan Chung
Journal:  Respir Res       Date:  2004-11-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.